• Return to Headlines

Shares of Cambrex Corp Rank the Lowest in Terms of Debt-to-Capital Ratio in the Life Sciences Tools & Services Industry (CBM, BIO, PACB, TECH, ILMN)

By Amy Schwartz

Below are the three companies in the Life Sciences Tools & Services industry with the lowest Debt-to-Capital ratios. The debt-to-capital ratio is an important measure of how a company is financing its operations along with some insight into its financial strength, relative to other companies in its industry.

Cambrex Corp ranks lowest with a a Debt-to-Capital ratio of 668.0%. Following is Bio-Rad Labs-A with a a Debt-to-Capital ratio of 1,292.6%. Pacific Bioscien ranks third lowest with a a Debt-to-Capital ratio of 1,367.1%.

Bio-Techne Corp follows with a a Debt-to-Capital ratio of 2,657.9%, and Illumina Inc rounds out the bottom five with a a Debt-to-Capital ratio of 2,864.7%.

SmarTrend recommended that subscribers consider buying shares of Bio-Rad Labs-A on January 11th, 2019 as our technology indicated a new Uptrend was in progress when shares hit $240.10. Since that recommendation, shares of Bio-Rad Labs-A have risen 21.6%. We continue to monitor Bio-Rad Labs-A for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: lowest debt-to-capital ratio cambrex corp bio-rad labs-a pacific bioscien bio-techne corp illumina inc

Ticker(s): CBM BIO PACB TECH ILMN